ComInnex, Inc.

ComInnex, Inc.

August 08, 2013 10:00 ET

ComInnex Featured in Chemical & Engineering News for Its Innovative Technologies, Business Approach and Commercial Success

BUDAPEST, HUNGARY--(Marketwired - Aug. 8, 2013) - ComInnex, Inc., a privately held contract research and integrated discovery service organization announced today that the company was featured in the July 22nd issue of Chemical & Engineering News, the largest chemistry related magazine that is distributed to more than 140,000 readers worldwide.

The article introduced ComInnex as an innovative company that successfully utilizes novel patented technologies to differentiate itself on the discovery chemistry service market thereby creating unique value to its clients and customers. With ComInnex' technology clients can reach into a chemical parameter space and can create novel IP differentiated compounds that no other company can readily access.

Moreover, the company's history was also featured as it was established by the former management of ComGenex and AMRI Hungary. The Board of Directors is composed of experienced seasoned entrepreneurs in the pharmaceutical research and CRO business. Dr. Ferenc Darvas, founder of ComGenex and Chairman of the ComInnex Board and Dr. Laszlo Urge, former CEO of ComGenex and ThalesNano Inc.

The article highlighted the competitive value that collaborations with ComInnex' sister companies such as ThalesNano can bring to ComInnex' clients that has already delivered fruits in the form of novel technologies having been put into real word customer projects. These technologies and applications provide key benefits to the company's current and future client base and will help serve their needs more effectively.

"We feel that it is a great recognition that our company has been featured in the most prestigious journal of the chemistry community of the world. We will continue our pursuit for innovation in order to better serve our clients and stay competitive in the challenging marketplace," commented Dr. Gergely Makara, CEO of ComInnex.

About ComInnex:

ComInnex, Inc. is a custom chemistry, medicinal chemistry and chemical library provider in the EU with strong background in new chemical technologies. Its chemistry, medicinal chemistry and technology platform was formed via the fusion of powerful chemistry technology innovation at ComInnex with the outstanding chemistry and medicinal chemistry expertise of the former AMRI Hungary. Beyond offering excellence in traditional contract research, the company is also a breeding ground for innovative technologies in the service of chemistry and medicinal chemistry research: a partner where technology and medicinal chemistry meet to access novel and unique chemical space.

Board of Directors: Dr. Ferenc Darvas, Dr. Laszlo Urge, Dr. Ferenc Kalman, Erzsebet Tari Palne, Dr. Gergely Makara.

Contact Information